LIAISON BORRELIA IGG
ENSAYO INMUNOLÓGICOQUE EMPLEA LA TECNOLOGÍA DE QUIMIOLUMINISCENCIA (CLIA) PARA LA DETERMINACIÓN CUALITATIVA DE LOS ANTICUERPOS ESPECÍFICOS DE CLASE IGG DIRIGIDOS CONTRA BORRELIA BURGDORFERI SENSU LATO EN MUESTRAS DE SUERO, PLASMA O LÍQUIDO CEFALORRAQUÍDEO
IMMUNOASSAY USING CHEMILUMINESCENCE TECHNOLOGY (CLIA) FOR THE QUALITATIVE DETERMINATION OF SPECIFIC IGG ANTIBODIES DIRECTED AGAINST BORRELIA BURGDORFERI SENSU LATO IN SERUM, PLASMA OR CEREBROSPINAL FLUID SAMPLES
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- REACTIVO PARA LA DETECCIÓN DE LA BORRELIA BURGDORFERI
- Trade Name (English)
- REAGENT FOR THE DETECTION OF BORRELIA BURGDORFERI
- Analysis ID
- 2065R2018 SSA
- Registration Date
- August 23, 2018
- Name (Spanish)
- DIASORIN MÉXICO, S.A. DE C.V.
- Name (English)
- DIASORIN MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for LIAISON BORRELIA IGG (LIAISON BORRELIA IGG) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 2065R2018 SSA and manufactured by DIASORIN MÉXICO, S.A. DE C.V.. The device was registered on August 23, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.